The Division of Cancer Prevention supports major scientific collaborations, research networks, investigator-initiated grants, postdoctoral training, and specialized resources across the United States.
Programs with Independent Websites
Cancer Prevention Fellowship Program (CPFP)
Advanced training for fellows provides a strong foundation in the field of cancer prevention and control to scientists and clinicians from varied health disciplines.
Consortium for Molecular Characterization of Screen-Detected Lesions
Seven laboratories and a coordinating center focus on identifying screening-detected pre-cancers and early cancers, including within the tumor microenvironment.
Early Detection Research Network (EDRN)
Labs and centers bring together comprehensive infrastructure and resources critical to discovery, development and validation of biomarkers for cancer risk and early detection.
NCI Community Oncology Research Program (NCORP)
A clinical trials network of cancer professionals brings research to diverse populations across the country in the communities where most patients live.
Programs with Webpages within This Site
Adductomics Research Program (ARP)
This program promotes adducts/adductomics research-based strategies to identify a wide variety of molecular signatures for assessing risks, both exogenous and endogenous, as well as the combined effects to aid in optimization of cancer screening and prevention strategies
Alliance of Glycobiologists for Cancer Research
Tumor Glycomics Laboratories work to reveal cancer-related dynamics of complex carbohydrates.
Barrett's Esophagus Translational Research Network (BETRNet)
Multi-disciplinary Research Centers collaborate to enhance understanding of Barrett's esophagus and prevent esophageal adenocarcinoma.
Cancer Prevention Clinical Trials Network (CP-CTNet)
Research Centers develop and conduct early phase clinical trials to assess the preventive potential of agents and interventions of varying classes.
Consortium for Imaging and Biomarkers (CIB)
Research Units integrate imaging strategies with biomarkers to improve cancer screening, early detection of aggressive cancer, assessment of cancer risk, and diagnosis of early stage cancer.
Liquid Biopsy Consortium
A partnership with academic and industrial laboratory teams developing noninvasive liquid biopsy techniques to detect early stage cancer from biomarkers in blood, urine and sputum.
Pancreatic Cancer Detection Consortium (PCDC)
Research teams develop and test new molecular and imaging biomarkers to detect early stage pancreatic ductal adenocarcinoma and its precursor lesions.
Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
Major medical research centers conduct systematic early clinical development of promising preventive agents.
PREVENT Cancer Preclinical Drug Development Program (PREVENT)
The peer-reviewed research pipeline supports new prevention interventions and biomarkers headed toward clinical trials.
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection
This program isolates and characterizes exosomes and their cargo for discovery of predictive biomarkers for risk assessment, detection, diagnosis and prognosis of early cancer.
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
A large randomized trial designed to determine the effects of screening on cancer-related mortality and secondary endpoints in people aged 55 to 74. Researchers can request valuable PLCO data and biospecimens.
Small Cell Lung Cancer (SCLC) Consortium
Six investigators conduct research to expand the understanding of the critical molecular changes in the lung that precede the development of frank SCLC and/or to identify populations at particularly high risk for SCLC.
Supportive Care and Symptom Management
Clinical trials and grant-funded projects examine symptoms and morbidities related to cancer and its treatment, with a focus on interventions to improve quality of life.
Translational Liver Cancer (TLC) Consortium
Five Translational Research Centers conduct studies to improve surveillance of liver cancer in high-risk populations, increase detectability at early stages, and stratify at-risk patients.
US-Latin American-Caribbean Clinical Trials Network (ULACNet)
Partnership Centers will focus on improving prevention of human papillomavirus (HPV)-related cancers in human immunodeficiency virus (HIV)-infected individuals.
Research Networks Map
The Division of Cancer Prevention supports major scientific collaborations and research networks at more than 100 sites across the United States.